Introduction to Canadian Cannabis regulations: GMP/GPP
IPA is pleased to organize this virtual complimentary live presentation sponsored by Demberg PharmaSolutions.
Date: March 2, 2022 | Time: 11:00 AM – 12:00 PM ET
Good Production Practices (GPP) and current Good Manufacturing Practices (cGMP)are the foundation of cannabis production. By being part of a cGMP/GPP-related activities , this webinar is a perfect way to introduce yourself to proper manufacture and control products in highly regulated environment. This webinar is the first introduction to the current Good Manufacturing Practices (cGMP) and Good Production Practices (GPP) in the cannabis environment. The basic cGMP/GPP requirements for people, buildings, contamination control, and Quality System will be discussed and explained, and a few examples will be provided.
About the presenters:
Natasha Demberg is a Quality and BD Executive in the Life Science and Health Care industries such as Pharmaceutical, Cosmetics, Medical Devices, Natural Health Products, Cannabis, and Biotechnology. She has 30+ years in the development and application of Quality Management Systems throughout the product life cycle (development, scale-up, and commercialization) and Business Development for Pharmaceutical service providers. She is experienced in leading multi-functional groups to address challenging global regulatory compliance issues, develop strategy for Quality and Business Development, and create company culture oriented to Quality and Customer needs. Mrs. Demberg has Quality and Compliance expertise that spans cGMP compliance-Regulatory Bodies inspections, ISO and NIOSH certifications. Mrs. Demberg is an expert in PAI readiness, FDA and HC Mock Inspections, internal audits and suppliers and vendors audits and qualifications. As a BD executive Mrs. Demberg has an expertise of creating the client and business-oriented company culture, efficient customer support and services.
Currently, Mrs. Demberg is the leader of Demberg PharmaSolutions (DPS) consulting company that provides Quality & Compliance, consulting services for firms in the Life Science and Health Care industries for medical devices, pharmaceutical, cosmetic, cannabis, natural health, and investigational products. . DPS helps their clients in the creation of an efficient QMS that supports the business needs, DPS also performs thorough internal investigations, CAPAs and Deviations. In addition to Quality & Compliance, DPS works with all the departments to create a quality and business-oriented company culture and align objectives to the client’s business needs.
Natasha is known for her dynamic leadership style and her ability to think strategically and outside of the box. She brings with her the tremendous mix of technical expertise, regulatory knowledge, and her business sense. Due to her ability to operate on an executive level she brings together business and quality and develops a common language between the two.
Mrs. Demberg’s career has included a wide range of successful leadership positions in Quality Organizations of several companies in the pharmaceutical field. Initially as a chemist at Teva and Abbott Laboratory and later as Senior GMP Compliance Associate at Merck Frosst Canada, responsible for Quality aspect of Clinical manufacturing, Confab Laboratory Director of Quality Operations, Vice President of Quality Operations at Valeant Canada and Vice President of Operations and Pharmaceutical Solutions at Neopharm Labs, and many others. Currently Natasha is the Founder and President of Demberg PharmaSolutions (DPS).
Natasha holds a BSc in Chemical Engineering, a MSc in Chemistry of Polymers, Six Sigma Green Belt Certification, and is a member of the Quebec Chapter of the Society of Chemists, L’Ordre des chimistes du Québec.
Natasha is an Industry Speaker on Quality and GMP Compliance in the Life Science Industry, program of Pharmaceutical Technology at John Abbott and various GMP conferences and seminars.
